Autolus Therapeutics plc (AUTL)
NASDAQ·Healthcare·Biotechnology
$1.60
+3.23%
Mkt Cap $431.15M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$8.87
Range $7.60 – $11.00
Implied Upside
+454.4%
Consensus $8.87 vs current $1.60
NASDAQ·Healthcare·Biotechnology
$1.60
+3.23%
Mkt Cap $431.15M
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$8.87
Range $7.60 – $11.00
+454.4%
Consensus $8.87 vs current $1.60